1. Home
  2. TNDM vs IART Comparison

TNDM vs IART Comparison

Compare TNDM & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNDM
  • IART
  • Stock Information
  • Founded
  • TNDM 2006
  • IART 1989
  • Country
  • TNDM United States
  • IART United States
  • Employees
  • TNDM N/A
  • IART N/A
  • Industry
  • TNDM Medical/Dental Instruments
  • IART Medical/Dental Instruments
  • Sector
  • TNDM Health Care
  • IART Health Care
  • Exchange
  • TNDM Nasdaq
  • IART Nasdaq
  • Market Cap
  • TNDM 1.1B
  • IART 978.4M
  • IPO Year
  • TNDM 2013
  • IART 1995
  • Fundamental
  • Price
  • TNDM $15.40
  • IART $12.31
  • Analyst Decision
  • TNDM Buy
  • IART Hold
  • Analyst Count
  • TNDM 13
  • IART 8
  • Target Price
  • TNDM $32.15
  • IART $18.17
  • AVG Volume (30 Days)
  • TNDM 1.7M
  • IART 1.1M
  • Earning Date
  • TNDM 08-06-2025
  • IART 07-31-2025
  • Dividend Yield
  • TNDM N/A
  • IART N/A
  • EPS Growth
  • TNDM N/A
  • IART N/A
  • EPS
  • TNDM N/A
  • IART N/A
  • Revenue
  • TNDM $982,951,000.00
  • IART $1,621,738,000.00
  • Revenue This Year
  • TNDM $8.91
  • IART $5.56
  • Revenue Next Year
  • TNDM $10.94
  • IART $4.41
  • P/E Ratio
  • TNDM N/A
  • IART N/A
  • Revenue Growth
  • TNDM 27.65
  • IART 3.53
  • 52 Week Low
  • TNDM $14.31
  • IART $11.06
  • 52 Week High
  • TNDM $47.60
  • IART $27.13
  • Technical
  • Relative Strength Index (RSI)
  • TNDM 40.09
  • IART 47.35
  • Support Level
  • TNDM $15.21
  • IART $12.27
  • Resistance Level
  • TNDM $17.19
  • IART $14.07
  • Average True Range (ATR)
  • TNDM 0.85
  • IART 0.66
  • MACD
  • TNDM 0.20
  • IART 0.07
  • Stochastic Oscillator
  • TNDM 37.85
  • IART 41.14

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Share on Social Networks: